.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Express Scripts
Accenture
Daiichi Sankyo
Dow
Novartis
Healthtrust
Chubb
Colorcon

Generated: November 24, 2017

DrugPatentWatch Database Preview

PREDNISONE - Generic Drug Details

« Back to Dashboard

What are the generic sources for prednisone and what is the scope of prednisone freedom to operate?

Prednisone
is the generic ingredient in thirteen branded drugs marketed by Halsey, West-ward Pharms Int, Marshall Pharma, Mutual Pharm, Vangard, Inwood Labs, Vitarine, Phoenix Labs Ny, Solvay, Contract Pharmacal, Roxane, Muro, Elkins Sinn, Jubilant Cadista, Aurolife Pharma Llc, Watson Labs, Whiteworth Town Plsn, Lannett, Nylos, Heather, Horizon Pharma, Lederle, Wockhardt, Mylan Pharms Inc, Rexall, Ivax Sub Teva Pharms, Kv Pharm, Sandoz, Valeant Pharm Intl, Hikma Pharms, Everylife, Sun Pharm Inds, Panray, Pvt Form, Purepac Pharm, Schwarz Pharma, Vintage Pharms, Chartwell Rx, Sperti, Parke Davis, Pharmavite, Ferrante, Ferndale Labs, Superpharm, Schering, Actavis Labs Fl Inc, Upsher Smith, Scherer Labs, Bundy, Impax Labs, UDL, Pharmacia And Upjohn, Am Therap, Bayer Pharms, Duramed Pharms Barr, Amneal Pharms Ny, and Teva, and is included in one hundred and nineteen NDAs. There are eight patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Prednisone has sixty-eight patent family members in thirty countries.

There are sixteen drug master file entries for prednisone. Fifty-six suppliers are listed for this compound.

Medical Subject Heading (MeSH) Categories for PREDNISONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Superpharm
PREDNISONE
prednisone
TABLET;ORAL088866-001Oct 25, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Duramed Pharms Barr
PREDNISONE
prednisone
TABLET;ORAL088395-001Oct 4, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Lederle
SERVISONE
prednisone
TABLET;ORAL080223-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Whiteworth Town Plsn
PREDNISONE
prednisone
TABLET;ORAL084913-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Vintage Pharms
PREDNISONE
prednisone
TABLET;ORAL040256-002Jul 12, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe
Panray
PREDNISONE
prednisone
TABLET;ORAL080350-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Horizon Pharma
RAYOS
prednisone
TABLET, DELAYED RELEASE;ORAL202020-001Jul 26, 2012ABRXYesNo► Subscribe► Subscribe ► Subscribe
Horizon Pharma
RAYOS
prednisone
TABLET, DELAYED RELEASE;ORAL202020-002Jul 26, 2012ABRXYesNo► Subscribe► Subscribe ► Subscribe
Wockhardt
PREDNISONE
prednisone
SOLUTION;ORAL089726-001Aug 2, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
PREDNISONE
prednisone
TABLET, DELAYED RELEASE;ORAL204867-002Apr 25, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: prednisone

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,920,838Delayed-release glucocorticoid treatment of rheumatoid disease► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: prednisone

Country Document Number Estimated Expiration
Eurasian Patent Organization015304► Subscribe
South Korea20060015528► Subscribe
MexicoPA05011446► Subscribe
Japan2009545546► Subscribe
China1777412► Subscribe
European Patent Office1318816► Subscribe
Japan2002539167► Subscribe
Singapore10201503411Q► Subscribe
CroatiaP20130148► Subscribe
Japan2004511445► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Chubb
Cipla
Cerilliant
Covington
Accenture
Express Scripts
Johnson and Johnson
UBS
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot